aTyr Pharma Inc (LIFE) stock has risen 218.13% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives LIFE stock a score of 85 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 100. LIFE's rank also includes a short-term technical score of 84. The fundamental score for LIFE is 70. In addition to the average rating from Wall Street analysts, LIFE stock has a mean target price of $19.25. This means analysts expect the stock to increase 56.76% over the next 12 months.
LIFE has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on LIFE!
aTyr Pharma Inc (LIFE) stock has risen 6.59% while the S&P 500 has risen 1.22% as of 10:41 AM on Thursday, Sep 23. LIFE has risen $0.76 from the previous closing price of $11.52 on volume of 1,653,366 shares. Over the past year the S&P 500 is up 37.45% while LIFE has risen 218.13%. LIFE lost -$2.29 per share in the over the last 12 months.
Click Here to get the full Stock Report for aTyr Pharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
